FDA recall, , Moderate risk
Micro Labs Dorzolamide HCl and Timolol Maleate Ophthalmic Solution
Dorzolamide HCl and Timolol Maleate Ophthalmic Solution has defective container caps that may break.
Summary by Recall Canary from the FDA notice
What happened
Micro Labs USA Inc., of Somerset, New Jersey, recalled Dorzolamide HCl and Timolol Maleate Ophthalmic Solution, USP, 2%/0.5%, 10mL, after receiving multiple complaints of broken cap spikes and undeliverable drops. The product, manufactured by Micro Labs Limited, India, and distributed nationwide in the USA, was recalled starting July 22, 2026, and added to the FDA's Enforcement Report on July 24, 2026.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Match the NDC and lot code listed under your product.
An NDC (National Drug Code) is usually printed on the drug's label.
- NDC
- 42571-147-26
- Lot code
- DLHU0031
Recall details
- Company began the recall
- Sold in
Nationwide in the USA.
- Company
- MICRO LABS USA INCSomerset, New Jersey
- Hazard
- Packaging defect
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99481
- Recall number
- D-0730-2026
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA
Listed on Recall Canary
In FDA's weekly enforcement report
Summary updated
